Partner news
News
Partner news
Exonate Announces Collaboration with Janssen to develop a new eye drop for the treatment of retinal vascular diseases including wet age-related macular degeneration (AMD) and diabetic macular oedema (DMO)
Read full storyPartner news
Medicines Discovery Catapult, MQ: Transforming mental health and Alzheimer’s Research UK announce an innovative drug discovery consortium with industry, supported by the Wellcome Trust.
Read full storyPartner news
TU Dresden announces collaboration with Janssen to advance next-generation nuclease-free gene editing platform
Read full storyPartner news
AdoRx Therapeutics Announces Collaboration with Johnson & Johnson Innovation to Develop Novel Lung Cancer Therapeutics
Read full storyPartner news
New strategic partners join £9.5 million dementia drug discovery collaboration
Read full storyPartner news
Philogen Announces Drug Discovery Collaboration With Johnson & Johnson Innovation
Read full storyPartner news
BiomX Enters Collaboration with Johnson & Johnson Innovation for Discovery of Microbiome-based Biomarkers for IBD
Read full storyPartner news
Vect-Horus Announces Agreement With Johnson & Johnson Innovation
Read full storyPartner news
Ad Scientiam announces agreement with Johnson & Johnson Innovation to develop a digital assessment scale for Major Depressive Disorders
Read full storyPartner news
Touchlight announces collaboration with Janssen Biotech
Read full storyPartner news
Dreem Announces $35 Million Financing from lead investors Johnson & Johnson Innovation – JJDC, Inc. (JJDC) and Bpifrance to Accelerate Innovations in the Field of Sleep Science
Read full storyJNJ Press releases
Zebra Medical Vision raises $30 million
Read full storyPartner news
Nuevolution to receive license fee payment of USD 750,000
Read full storyPartner news